Hematopoietic SCT in children with Griscelli syndrome: A single-center experience

Bone Marrow Transplantation

Volumn 45, Issue 8, 2010, Pages 1294-1299

  Al Ahmari, A ^a   Al Ghonaium, A ^a   Al Mansoori, M ^a   Hawwari, A ^a   Eldali, A ^a   Ayas, M ^a   Al Mousa, H ^a   Al Jefri, A ^a   Al Saud, B ^a   Al Seraihy, A ^a   Al Muhsen, S ^a   Al Mahr, M ^a   Al Dhekri, H ^a   El Solh, H ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

familial hemophagocytic lymphohistiocytosis; Griscelli syndrome; hematopoietic SCT

Indexed keywords

ACICLOVIR; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; IMMUNOGLOBULIN; MEPREDNISONE; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN RECOGNITION; ARTICLE; CHILD; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DEVELOPMENTAL DISORDER; DISEASE FREE SURVIVAL; DRUG DOSE TITRATION; FEMALE; GRAFT VERSUS HOST REACTION; GRISCELLI SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SEPTIC SHOCK; SPEECH DISORDER; SURVIVAL RATE; TREATMENT RESPONSE; VEIN OCCLUSION;

CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; PIEBALDISM; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77955582316     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.358     Document Type: Article

References (28)

1. Griscelli C, Durandy A, Guy-Grand D, Daguillard F, Herzog C, Prunieras M. A syndrome associating partial albinism and immunodeficiency. Am J Med 1978; 65: 691-702.
2. Siccardi AG, Bianchi E, Calligari A, Clivio A, Fortunato A, Magrini U et al. A new familial defect in neutrophil bactericidal activity. Helv Paediatr Acta 1978; 33: 401-412.
3. Pastural E, Barrat FJ, Dufoureq-Lagelouse R, Certain S, Sanal O, Jabade N et al. Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin Va gene. Nat Genet 1997; 16: 289-292.
4. Sanal O, Yel L, Kucukali T, Gilbert-Barnes E, Tardieu M, Tezcan I et al. An allelic variant of Griscelli disease: presentation with severe hypotonia mental-motor retardation, and hypopigmentation consistent with Elejalde syndrome (neuroectodermal melanolysosomal disorder). J Neurol 2000; 247: 570-572.
5. Menasche G, Ho CH, Sanal O, Feldmann J, Tezcan I, Ersoy F et al. Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). J Clin Invest 2003; 112: 450-456.
6. Klein C, Philippe N, Le Deist F, Fraitag S, Prost C, Durandy A et al. Partial albinism with Immunodeficiency (Griscelli syndrome). J Pediatr 1994; 125: 886-895.
7. Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S et al. Mutations in RAB27A cause Griscelli syndrome associated with hemophagocytic syndrome. Nat Genet 2000; 25: 173-176.
8. Kumar M, Sackey K, Schmalstieg F, Trizna Z, Elghetany MT, Alter BP. Griscelli syndrome: a rare neonatal syndrome of recurrent hemophagocytosis. J Pediatr Hematol Oncol 2001; 23: 464-468.
9. Schneider L, Berman R, Shea C, Perez-Atayde A, Weinstein H, Geha R. Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome). J Clin Immunol 1990; 10: 146-153.
10. Baumeister F, Stachel D, Schuster F, Schmid I, Schaller M, Wolff H et al. Accelerated phase in partial albinism with immunodeficency (Griscelli syndrome): genetics and stem cell transplantation in a 2-month-old girl. Eur J Pediatr 2000; 159: 74-78.
11. Fischer A, Griscelli C, Friedrich W, Kubanek B, Levinsky R, Morgan G et al. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European Survey 1968-1985. Lancet 1986; 2: 1080-1084.
12. Arico M, Zecca M, Santoro N, Caselli D, Maccario R, Danesino C et al. Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 995-998.
13. Tezcan I, Sanal O, Ersoy F, Uckan D, Kilic S, Metin A et al. Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement. Bone Marrow Transplant 1999; 24: 931-933.
14. Schuster F, Stachel DK, Schmid I, Baumeister FA, Graubner UB, Weiss M et al. Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT. Bone Marrow Transplant 2001; 28: 409-412.
15. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991; 18: 29-33.
16. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.
17. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M. Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 794-800.
18. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of GVHD in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-299.
19. Atkinson K, Horowitz MM, Gale RP, Lee MB, Rimm AA, Bortin MM. Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Bone Marrow Transplant 1989; 4: 247-254.
20. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH et al. Treatment of Hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
21. Horne A, Janka G, Egeler RM, Gadner H, Imashuku S, Ladisch S et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129: 622-630.
22. Baker KS, DeLaat CA, Steinbuch M, Gross TG, Shapiro RS, Loechelt B et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow. Blood 1997; 89: 3857-3863.
23. Haddad BE, Le Deist F, Blanche S, Benkerrou M, Rohrlich P, Vilmer E et al. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases. Blood 1995; 85: 3328-3333.
24. Henter JI, Samuelsson-Horne AC, Maurizio A, Egeler RM, Elinder G, Filipovich AH et al. Treatment of Hemophagocytic lymphohistiocytosis with HLH-94 immuno-chemotherapy and bone marrow transplantation. Blood 2002; 100: 2367-2373.
25. Ouachee-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis. A single-center report of 48 patients. Pediatrics 2006; 117: e743-e750. DOI: 10.1542/peds.2005-1789. (Pubitemid 46071479)
26. Pachlopnik Schmid J, Moshous DM, Cavazzana-Calvo M, Blanche S, de Saint Basile G, Fischer A. Haematopoietic stem cell transplantation in Griscelli Syndrome type 2: a single center report of 10 patients. Bone Marrow Transplant 2009; 43(Suppl 1): S182 (abstract 686).
27. Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsahin H, Wacker P. Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347-354.
28. Landman-Parker J, Le Deist F, Blaise A, Brison O, Fischer A. Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistio- cytosis. Br J Haematol 1993; 85: 37-41.